PP

Active Director Director DIN 10060753
DIN 10060753 First appointment Mar 2023 Primary industry Paper
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2023
Shareholding value •••• Premium profile

About Priti Pal

Data last updated:

Priti Pal is a Director at Kegel Pharmaceuticals Private Limited (since 2023). The company operates in Paper. Kegel Pharmaceuticals Private Limited reported revenue of ₹20.9 Lakh (FY 2025).

DIN 10060753
Primary Designation Director
Industry Paper
First Appointment 03 Mar 2023
Oldest Company Age 3 yrs
Largest company Kegel Pharmaceuticals Private Limited · ₹20.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director03 Mar 20232023₹20.9 Lakh (FY 2025)Active

Board colleagues of Priti Pal

NameDINCompanyDesignation
Manoj Kumar Pandit10060754Kegel Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Kegel Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Priti Pal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Priti Pal

Priti Pal currently holds 1 directorship: Kegel Pharmaceuticals Private Limited (Director, since 03 Mar 2023, revenue ₹20.9 Lakh (FY 2025)).

Priti Pal was first appointed on 03 Mar 2023 as Director at Kegel Pharmaceuticals Private Limited.

The current boards of Priti Pal's companies include Manoj Kumar Pandit (Kegel Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available